Brief: China Regenerative Medicine International QTRLY Revenue From Cont Ops HK$64.1 Mln
11/11/2020 14:32
Nov 11 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK :
* QTRLY REVENUE FROM CONTINUING OPERATIONS HK$64.1 MILLION
VERSUS
HK$5.4 MILLION
* QTRLY LOSS ATTRIBUTABLE HK$18.3 MILLION VERSUS LOSS OF
HK$22.2
MILLION
Source text for Eikon: ID:nHKS3BJzLs
Further company coverage: 8158.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital